Chargement en cours...

Circasemidian rather than circadian variation of circulating osteoprotegerin in clinical health

Osteoprotegerin (OPG) serves as a soluble decoy receptor for RANKL to inhibit osteoclast formation and activity. Hormones such as PTH and glucocorticoids have been reported to decrease OPG concentrations, while estrogens, transforming growth factor b, related bone morphogenic factor and thrombopoiet...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tarquini, R., Mazzoccoli, G., Dolenti, S., Gaudiano, P., Comuni, C., Laffi, G., Perfetto, F., Otsuka, K., Corné1issen, G., Halberg, F.
Format: Artigo
Langue:Inglês
Publié: 2005
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2631572/
https://ncbi.nlm.nih.gov/pubmed/16275499
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!